Suppr超能文献

日本患者中CoreValve和SAPIEN-XT经导管主动脉瓣置换术瓣膜的血流动力学比较。

Hemodynamic comparison of CoreValve and SAPIEN-XT TAVI valves in Japanese patients.

作者信息

Shishido Koki, Yamanaka Futoshi, Ochiai Tomoki, Yamabe Tsuyoshi, Noguchi Kenichiro, Ota Takashi, Koide Yasuhiro, Ogino Hidemitsu, Tanaka Yutaka, Saito Shigeru

机构信息

Department of Cardiology, Shonan Kamakura General Hospital, Okamoto 1370-1, Kamakura, 247-8533, Japan.

Department of Cardiovascular Surgery, Shonan Kamakura General Hospital, Kamakura, Japan.

出版信息

Heart Vessels. 2019 Oct;34(10):1674-1683. doi: 10.1007/s00380-019-01414-0. Epub 2019 Apr 16.

Abstract

Transcatheter aortic valve implantation (TAVI) is a viable treatment option for high-risk patients with severe aortic stenosis. In Japan, TAVI can be performed using first-generation self-expandable Medtronic CoreValve or balloon-expandable Edwards SAPIEN-XT from 2012. Since the durability and hemodynamic outcomes after transcatheter heart valve (THV) implantation in Japanese patients have not been clearly elucidated, we assessed serial changes in post-TAVI THV performances over a-3-year period by transthoracic echocardiography (TTE). From January 2012 to September 2014, among 83 patients with severe aortic stenosis, 26 underwent TAVI with CoreValve and 57 underwent TAVI with SAPIEN-XT. We assessed the serial changes in first post-implant (FPI) and 3-year post procedure THV hemodynamics by TTE. Valve performance was evaluated by serial assessment of aortic valve mean pressure gradient (PG) and aortic valve area (AVA) assessments. Three-year clinical outcomes were compared between the patients with CoreValve and those with SAPIEN-XT. Seventeen patients with CoreValve and 34 patients with SAPIEN-XT had FPI and 3-year TTEs. The AVA decreased significantly from FPI to 3-year follow-up among patients with SAPIEN-XT, but not among patients with CoreValve. The mean aortic PG decreased significantly from FPI to the 3-year follow-up point among patients with CoreValve; however, it was not significantly different from those with SAPIEN-XT. The absolute change in mean PG from FPI to the 3-year follow-up point decreased significantly among those with CoreValve compared to those with SAPIEN-XT. Clinical outcomes after TAVI were similar for both devices at 3-years after TAVI. In this study, long-term clinical outcomes for CoreValve and SAPIEN XT were similar. The 3-year THV performance of both devices was maintained after TAVI. Serial change in mean aortic PGs for CoreValve decreases significantly from FPI to the 3-year follow-up point compared to that for SAPIEN-XT.

摘要

经导管主动脉瓣植入术(TAVI)是治疗高危重度主动脉瓣狭窄患者的一种可行选择。在日本,自2012年起可使用第一代自膨胀式美敦力CoreValve或球囊扩张式爱德华兹SAPIEN-XT进行TAVI。由于日本患者经导管心脏瓣膜(THV)植入后的耐久性和血流动力学结果尚未明确阐明,我们通过经胸超声心动图(TTE)评估了TAVI术后3年内THV性能的系列变化。2012年1月至2014年9月,在83例重度主动脉瓣狭窄患者中,26例接受了CoreValve TAVI,57例接受了SAPIEN-XT TAVI。我们通过TTE评估了首次植入后(FPI)和术后3年THV的血流动力学系列变化。通过对主动脉瓣平均压力阶差(PG)和主动脉瓣面积(AVA)的系列评估来评价瓣膜性能。比较了CoreValve组和SAPIEN-XT组患者的3年临床结局。17例CoreValve患者和34例SAPIEN-XT患者进行了FPI和3年TTE检查。SAPIEN-XT组患者从FPI到3年随访期间AVA显著降低,而CoreValve组患者则未降低。CoreValve组患者从FPI到3年随访点的平均主动脉PG显著降低;然而,与SAPIEN-XT组患者相比无显著差异。与SAPIEN-XT组相比,CoreValve组从FPI到3年随访点平均PG的绝对变化显著降低。TAVI术后3年,两种装置的临床结局相似。在本研究中,CoreValve和SAPIEN XT的长期临床结局相似。TAVI术后两种装置的3年THV性能均得以维持。与SAPIEN-XT相比,CoreValve从FPI到3年随访点平均主动脉PG的系列变化显著降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验